Basic Pharmacological Properties of Synthetic Analogues and Homologues of the Neurohypophysial Hormones

  • B. Berde
  • R. A. Boissonnas
Part of the Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology book series (HEP, volume 23)


During the last decade, nearly 200 analogues and homologues of the neurohypophysial hormones have been synthesised in various laboratories, and the biological activities of these synthetic peptides structurally related to the neurohypophysial hormones have been more or less extensively investigated. The principal aim of all this work was to try to establish relationships between the chemical structure and the biological activities of these hormones.


Synthetic Analogue International Unit United States Pharmacopeia Pharmacological Data Human Uterus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Acher, R., J. Chatjvet, M.T. Chauvet, et D. Crepy: Isolement d’une nouvelle hormone neurohypophysaire, l—isotocine, présente chez les poissons osseux. Biochim. biophys. Acta (Amst.) 58, 624 (1962).Google Scholar
  2. Aguet, F.: Les hémoptysies et leurs traitements. Schweiz, med. Wschr. 94, 628 (1964).Google Scholar
  3. Bangham, D.R., and M.V. Mussett: Third International Standard for Posterior Pituitary. Bull. Org. mond. Santé 19, 325 (1958).Google Scholar
  4. Beauvillain, A.: Titrage des préparations posthypophysaires par leur seuil d’action sur l’utérus isolé de rat adulte. C.R. Soc. Biol. (Paris) 137, 284 (1943).Google Scholar
  5. Beránková, Z., I. Rychlík, K. Jošt, J. Rudinger, and F. Šorm: Inhibition of the uterus-contracting effect of oxytocin by O-methyloxytocin. Coll. Czechoslov. Chem. Commun. 26, 2673 (1961).Google Scholar
  6. Beránková-Ksandrová, Z., G.W. Bisset, K. Jošt, I. Krejčí, V. Pliška, J. Rudinger, I. Rychlík, and F. Šorm: Synthetic analogues of oxytocin acting as hormonogens. Brit. J. Pharmacol. 26, 615 (1966).PubMedGoogle Scholar
  7. Berde, B.: Les analogues synthétiques des hormones neurohypophysaires sont-ils une clef de l’étude des troubles de l’hormonogénèse de ce systeme? In: Les Troubles Congénitaux de l’Hormonogénèse, p. 33. Paris: Masson 1965.Google Scholar
  8. —, and R. A. Boissonnas: Synthetic analogues and homologues of the posterior pituitary hormones. In: The pituitary gland, p. 624. Ed. by G.W. Harris and B.T. Donovan. London: Butterworths 1966.Google Scholar
  9. —, R. Huguenin, and E. Stürmer: Vasopressin analogues with selective pressor activity. Experientia (Basel) 20, 42 (1964).Google Scholar
  10. —, u. A. Cerletti: Über die Wirkung pharmakologischer Oxytocindosen auf die Milchdrüse. Acta endocr. 34, 543 (1960).PubMedGoogle Scholar
  11. —: Über die antidiuretische Wirkung von synthetischem Lysin-Vasopressin. Helv. physiol. pharmacol. Acta 19, 135 (1961).Google Scholar
  12. —, and H. Konzett: The biological activity of a series of peptides related to oxytocin. In: Oxytocin, p. 247. Ed. by R. Caldeyro-Barcia and H. Heller. Oxford: Pergamon Press 1961a.Google Scholar
  13. —, W. Doepfner, and H. Konzett: Some pharmacological actions of four synthetic analogues of oxytocin. Brit. J. Pharmacol. 12, 209 (1957).PubMedGoogle Scholar
  14. —, and H. Konzett: Isoleucyl8-Oxytocin, ein biologisch hochwirksames Polypeptid. Med. Exp. 2, 317 (1960).Google Scholar
  15. — —, and E. Stürmer: Personal communication (1960).Google Scholar
  16. —, and K. Saameli: The action of the synthetic polypeptide valyl-oxytocin on the human uterus in vitro and in vivo. Acta endocr. (Kbh.) 32, 391 (1959).Google Scholar
  17. —: Evaluation of substances acting on the uterus. In: Methods in drug evaluation, p. 481. Ed. by P. Mantegazza and F. Piccinini. Amsterdam: North-Holland Publ. Co. 1966.Google Scholar
  18. —, and E. Stürmer: Personal communication (1962, 1964, 1965).Google Scholar
  19. —, H. Weidmann, and A. Cerletti: Über Phenylalanin2-Lysin-Vasopressin. Helv. physiol. pharmacol. Acta 19, 285 (1961b).PubMedGoogle Scholar
  20. Bodanszky, M., and C.A. Birkhimer: 8-L-citrulline vasopressin and 8-L-citrulline oxytocin. J. Amer. chem. Soc. 84, 4943 (1962a).Google Scholar
  21. —, M.A. Ondetti, B. Rubin, J.J. Piala, J. Fried, J.T. Sheehan, and C.A. Birkhimer: Biologically active citrulline peptides. Nature (Lond.) 194, 485 (1962 b).Google Scholar
  22. —, and V. Du Vigneaud: Synthesis of a biologically active analog of oxytocin, with phenyl-alanine replacing tyrosine. J. Amer. chem. Soc. 81, 1258 (1959).Google Scholar
  23. Boissonnas, R.A., and St. Guttmann: Synthèse d’analogues de roxytocine et de la lysine-vasopressine contenant de la phénylalanine ou de la tyrosine en positions 2 et 3. Helv. chim. Acta 43, 190 (1960).Google Scholar
  24. —, B. Berde, and H. Konzett: Relationships between the chemical structures and the biological properties of the posterior pituitary hormones and their synthetic analogues. Experientia (Basel) 17, 377 (1961).Google Scholar
  25. —, R.L. Huguenin, P.-A. Jaqtjenoud, and E.D. Sandrin: Synthèse de nouveaux analogues de la lysine-vasopressine (Asp[NH2]4-lysine-vasopressine, Ala4-lysine-vasopressine, Ser4-lysine-vasopressine, Ser-lysine-vasopressine, Val-lysine-vasopressine et [Nɛ-For-Lys]8-vasopressine). Helv. chim. Acta 46, 2347 (1963).Google Scholar
  26. —, P.-A. Jaquenoud, and J.-P. Waller: Synthèse d’analogues structuraux de l’ocytocine. Helv. chim. Acta 39, 1421 (1956).Google Scholar
  27. Boissonnas, R.A., and R.L. Huguenin: Synthèse de la Lys8-oxytocine (lysine-vasotocine) et nouvelle synthèse de la lysine-vasopressine. Helv. chim. Acta 43, 182 (1960).Google Scholar
  28. —, J.-F. Pechère, and St. Guttmann: Personal communication (1959).Google Scholar
  29. Bosomworth, P.P.: Anesthetic implications of phenylalanine2-lysine8-vasopressin. J. New-Drugs 4, 221 (1964).Google Scholar
  30. Boura, A., and S.E. Dicker: An apparatus for the maintenance of a constant water load and the recording of urine flow in rats. J. Physiol. (Lond.) 122, 144 (1953).Google Scholar
  31. Branda, L. A., S. Drabarek, and V. Du Vigneaud: The synthesis and pharmacological properties of deamino-4-decarboxamido-oxytocin (l-ß-mercaptopropionic acid-4-α-aminobutyric acid-oxytocin). J. Biol. Chem. 241, 2572 (1966).PubMedGoogle Scholar
  32. —, and V. Du Vigneaud: Synthesis and pharmacological properties of 9-decarboxamido-oxytocin. J. Med. Chem. 9, 169 (1966). British Pharmacopoeia: The Pharmaceutical Press. London: 1963.PubMedGoogle Scholar
  33. Burghardt, E.: Zur Operationstechnik der diagnostischen Konisation. Geburtsh. u. Frauen-heilk. 23, 548 (1963).Google Scholar
  34. Cash, W. D., L. M. Mahaffey, A. S. Buck, D. E. Nettleton Jr., C. Romas, and V. Du Vigneaud: Synthesis and biological properties of 9-sarcosine oxytocin. J. Med. Pharm. Chem. 5, 413 (1962).Google Scholar
  35. —, and B.L. Smith: Synthesis and biological properties of l-Acetyl-8-lysine-vasopressin. J. Biol. Chem. 238, 994 (1963).PubMedGoogle Scholar
  36. Chan, W.Y., M. O’connell, and S.R. Pomeroy: Effects of the estrous cycle on the sensitivity of rat uterus to oxytocin and desamino-oxytocin. Endocrinology 72, 279 (1963).PubMedGoogle Scholar
  37. —, and V. Du Vigneaud: Comparison of the pharmacologic properties of oxytocin and its highly potent analogue, desamino-oxytocin. Endocrinology 71, 977 (1962).PubMedGoogle Scholar
  38. Chauvet, J., M.-T. Lenci, and R. Acher: Présence de deux vasopressines dans la neurohypophyse du poulet. Biochim. biophys. Acta 38, 571 (1960).PubMedGoogle Scholar
  39. Chimiak, A., and J. Rudinger: Amino acids and peptides. Liii. Synthesis and some biological properties of 3-O-methylthreonine-oxytocin. Collection Czech. Chem. Commun. 30, 2592 (1965); and personal communication.Google Scholar
  40. Coon, J. M.: A new method for the assay of posterior pituitary extracts. Arch. int. pharma-codyn. 62, 79 (1939).Google Scholar
  41. Crawford, R. A.D.: Preliminary trial of a new haemostatic, Octapressin-Sandoz. Brit. J. Ophthal. 49, 49 (1965).PubMedGoogle Scholar
  42. Cross, B.A., and G.W. Harris: The role of the neurohypophysis in the milk-ejection reflex. J. Endocr. 8, 148 (1951/52).Google Scholar
  43. Dekanski, J.: The quantitative assay of vasopressin. Brit. J. Pharmacol. 7, 567 (1952).PubMedGoogle Scholar
  44. Dettelbach, H. R.: A method for assaying small amounts of antidiuretic substances with notes on some properties of vasopressin. Amer. J. Physiol. 192, 379 (1958).PubMedGoogle Scholar
  45. Dicker, S.E.: A method for the assay of very small amounts of antidiuretic activity with a note on the antidiuretic titre of rats’ blood. J. Physiol. (Lond.) 122, 149 (1953).Google Scholar
  46. Doepfner, W., E. Stürmer, and B. Berde: On the corticotrophin-releasing activity of synthetic neurohypophysial hormones and some related peptides. Endocrinology 72, 897 (1963).PubMedGoogle Scholar
  47. Drabarek, S.: Analogues of oxytocin containing glycine in place of tyrosine, isoleucine, or glutamine. J. Amer. chem. Soc. 86, 4477 (1964).Google Scholar
  48. —, and V. Du Vigneaud: 2-D-Tyrosine-oxytocin and 2-D-Tyrosine-deamino-oxytocin, diastereoisomers of oxytocin and deamino-oxytocin. J. Amer. chem. Soc. 87, 3974 (1965).Google Scholar
  49. Dutta, A.S., and N. Anand: Synthesis of 9-ß-alanine-oxytocin and 4-D-glutamine-oxytocin. Indian J. Chem. 3, 232 (1965).Google Scholar
  50. —, and K. Kar: Synthesis and pharmacological activity of 4-D-glutamine-oxytocin, 5-D-asparagine-oxytocin and 4-D-glutamine-5-D-asparagine-oxytocin. J. Med. Chem. 9, 497 (1966).PubMedGoogle Scholar
  51. Dyke, H.B. Van, K. Adamsons Jr., and S.L. Engel: Aspects of the biochemistry and physiology of the neurohypophyseal hormones. Recent Progr. Hormone Res. 11, 1 (1955).Google Scholar
  52. Embrey, M. P.: The action of desamino-oxytocin on the human pregnant uterus. J. Endocr. 31, 185 (1965).PubMedGoogle Scholar
  53. Ferrier, B.M., D. Jarvis, and V. Du Vigneaud: Deamino-oxytocin, its isolation by partition chromatography on Sephadex and crystallization from water, and its biological activities. J. biol. Chem. 240, 4264 (1965).PubMedGoogle Scholar
  54. Ferrier, B. M., and V. Du Vigneaud: 9-Deamidooxytocin, an analog of the hormone containing a glycine residue in place of the glycinamide residue. J. Med. Chem. 9, 55 (1966).PubMedGoogle Scholar
  55. Fisher, S. J., J. Gehrig, and H. Green: Non-catechol amine vasopressor (PLV-2) for use as adjunct to local anesthesia. J. Amer. dent. Ass. 70, 1189 (1965).PubMedGoogle Scholar
  56. Flouret, G., and V. Du Vigneaud: The synthesis of D-oxytocin, the enantiomer of the posterior pituitary hormone, oxytocin. J. Amer. chem. Soc. 87, 3775 (1965).Google Scholar
  57. Follett, B.K., and H. Heller: Pharmacological characteristics of neurohypophysial hormones in lungfish and amphibians. Nature (Lond.) 199, 611 (1963).Google Scholar
  58. —: The neurohypophysial hormones of bony fishes and cyclostomes. J. Physiol. (Lond.) 172, 74 (1964a).Google Scholar
  59. —: The neurohypophysial hormones of lungfishes and amphibians. J. Physiol. (Lond.) 172, 92 (1964b).Google Scholar
  60. Fosker, A.P., and H.D. Law: Oxytocin and 4-glycine-oxytocin. J. chem. Soc. 1965, 4922.Google Scholar
  61. Gaddum, J.H., W. S. Peart, and M. Vogt: The estimation of adrenaline and allied substances in blood. J. Physiol. (Lond.) 108, 467 (1949).Google Scholar
  62. Garcia De Jalon, P., J. Bayo Bayo, y M. Garcia De Jalon: Sensible y nuevo método de valo-racion de adrenalina en utero aislado de rata (A sensitive and new method for the bioassay of adrenaline on the isolated rat uterus). Farmacoterap. act. 2, 313 (1945) [in Spanish].Google Scholar
  63. Golubow, J., W.Y. Chan, and V. Du Vigneaud: Effect of human pregnancy serum on avian depressor activities of oxytocin and desamino-oxytocin. Proc. Soc. exp. Biol. (N.Y.) 113, 113 (1963).Google Scholar
  64. —, and V. Du Vigneaud: Comparison of susceptibility of oxytocin and desamino-oxytocin to inactivation by leucine aminopeptidase and α-chymotrypsin. Proc. Soc. exp. Biol. (N.Y.) 112, 218 (1963).Google Scholar
  65. Green, H.D., and J.B. Blumberg: The use of a synthetic analogue of posthypophysial vasopressin (PLV-2) for local hemostasis. Surgery 58, 524 (1965).PubMedGoogle Scholar
  66. Guhl, U.: Die antidiuretische und pressorische Wirksamkeit von Arginin8-Vasopressin, Lysin8-Vasopressin und Phenylalanin2-lysin8-Vasopressin beim Menschen. Schweiz, med. Wschr. 91, 798 (1961).Google Scholar
  67. Guttmann, ST., B. Berde, and E. Stürmer: The synthesis and some pharmacological effects of serine4-isoleucine8-oxytocin, a probable neurohypophysial hormone. Experientia (Basel) 18, 445 (1962).Google Scholar
  68. —, and R.A. Boissonnas: Synthèse de dix analogues de l’oxytocine et de la lysine-vasopressine, contenant de la sérine, de l’histidine ou du tryptophane en position 2 ou 3. Helv. chim. Acta 43, 200 (1960).Google Scholar
  69. —: Synthèse de nouveaux analogues de l’oxytocine et de la vasopressine. Chimia (Zurich) 15, 575 (1961).Google Scholar
  70. —: Synthèse d’homologues de la lysine-vasopressine et de l’oxytocine contenant une séquence His-Sér ou Sér-His en position N-terminale. Helv. chim. Acta 45, 2517 (1962).Google Scholar
  71. —: Synthèse de la Sér4-oxytocine, de l’Ala4-oxytocine, de la Sér5-oxytocine et de l’Ala5-oxytocine. Helv. chim. Acta 46, 1626 (1963).Google Scholar
  72. —, P.-A. Jaquenoud, R.A. Boissonnas, H. Konzett, and B. Berde: Ein Nonapeptid mit Oxytocin hemmenden Eigenschaften. Naturwissenschaften 44, 632 (1957).Google Scholar
  73. Haemmerli, U.P.: Die Therapie der ösophagusvarizenblutung. Dtsch. med. Wschr. 90, 311 (1965).PubMedGoogle Scholar
  74. Hermann, P., u. M. Zaoral: Aminosäuren und Peptide. LVI. Synthese von Thialysin8-Vasopressin. Collection Czech. Chem. Commun. 30, 2817 (1965).Google Scholar
  75. Hershey, S. G., u. B.M. Altura: Behandlung des Schocks durch Beeinflussung der peripheren Zirkulation mit vasoaktiven Wirkstoffen. Eine mikrozirkulatorische Basis für die Therapie. Schweiz. med. Wschr. 96, 1467 und 1516 (1966).Google Scholar
  76. Hochuli, E.: Klinische Erfahrungen mit der lokalen Anwendung von Octapressin in der Gynäkologie und Geburtshilfe. Schweiz, med. Wschr. 92, 654 (1962).Google Scholar
  77. Holton, P.: A modification of the method of Dale and Laidlaw for standardization of posterior pituitary extract. Brit. J. Pharmacol. 3, 328 (1948).PubMedGoogle Scholar
  78. Hope, D.B.: The biological activity of analogues of oxytocin lacking basic and acidic groups. Brit. Pharmacol. Soc. Meeting, Oxford 1962.Google Scholar
  79. —, V.V.S. Murti, and V. Du Vigneaud: A highly potent analogue of oxytocin, desamino-oxytocin. J. biol. Chem. 237, 1563 (1962).Google Scholar
  80. V. Du Vigneaud —: Synthesis of l-hemi-D-cystine-oxytocin. J. Amer. chem. Soc. 85, 3686 (1963).Google Scholar
  81. —, and V. Du Vigneaud: Synthesis of desamino-desoxy-oxytocin, a biologically active analogue of oxytocin. J. biol. Chem. 237, 3146 (1962).Google Scholar
  82. Huguenin, R.L.: Synthèse de la Phe2-Orn8-vasopressine et de la Phe2-Orn8-oxytocine, deux analogues de la vasopressine doués d’une activité pressorique sélective. Helv. chim. Acta 47, 1934 (1964).Google Scholar
  83. —: Personal communication (1965).Google Scholar
  84. —: Synthèse de la désamino1-Orn8-vasopressine, de la désamino1-Phé2-Orn8-vasopressine, de la désamino1-Ile3-Orn8-vasopressine (= désamino1-Orn8-oxytocine) et de la désamino1-Phé2-Ile3-Orn8-vasopressine (= désamino1-Phé2-Orn8-oxytocine). Helv. chim. Acta 49, 711 (1966).Google Scholar
  85. —, and R.A. Boissonnas: Synthèse de la (N-méthyl-Tyr)2-oxytocine. Helv. chim. Acta 44, 213 (1961).Google Scholar
  86. —: Synthèses de la Phé2-arginine-vasopressine et de la Phé2-arginine-vasotocine et nouvelles synthèses de l’arginine-vasopressine et de l’arginine-vasotocine. Helv. chim. Acta 45, 1629 (1962).Google Scholar
  87. —: Synthèse de l’Orn8-vasopressine et de l’Orn8-oxytocine. Helv. chim. Acta 46, 1669 (1963).Google Scholar
  88. —: Synthèse de la désamino1-Arg8-vasopressine et de la désamino1-Phé2-Arg8-vasopressine, deux analogues possédant une activité antidiurétique plus élevée et plus sélective que celle des vasopressines naturelles. Helv. chim. Acta 49, 695 (1966).Google Scholar
  89. —, and St. Guttmann: Synthèse de l—Ala1-Ala6-Arg8-vasopressine et de l’Ala1-Ala1-Lys8-vasopressine, ainsi que de la (désamino-Ala)1-Ala6-Arg8-vasopressine et de la (désamino-Ala)1-Ala6Lys8-vasopressine. Helv. chim. Acta 48, 1885 (1965).PubMedGoogle Scholar
  90. —, E. Stürmer, R. A. Boissonnas, and B. Berde: Desamino-arginine-vasopressin, an analogue of arginine-vasopressin with high antidiuretic activity. Experientia (Basel) 21, 68 (1965).Google Scholar
  91. Jansson, I.: Effect of desamino-oxytocin on the human pregnant uterus at term. Acta obstet. gynec. scand. 45, 29 (1966).PubMedGoogle Scholar
  92. Jaquenoud, P.-A.: Synthèse de la Gly8-oxytocine, de l’Ala8-oxytocine et de la But8-oxytocine. Helv. chim. Acta 48, 1899 (1965).PubMedGoogle Scholar
  93. —, and R.A. Boissonnas: Synthèse de la Phé2-oxytocine. Helv. chim. Acta 42, 788 (1959).Google Scholar
  94. — —: Personal communication (1960).Google Scholar
  95. —: Synthèse de la Ileu8-oxytocine et de la Val8-oxytocine, deux analogues de l’oxytocine modifiés dans la chaîne latérale. Helv. chim. Acta 44, 113 (1961).Google Scholar
  96. —: Synthèse de l’Asp(NH2)4-oxytocine, de la Glu(NH2)5-oxytocine et de l’Asp(NH2)5-Glu(NH2)5-oxytocine. Helv. chim. Acta 45, 1601 (1962a).Google Scholar
  97. —: Synthèse de la Dé-Pro7-oxytocine, de la Dé-Leu8-oxytocine et de la Dé-Gly9-oxytocine. Helv. chim. Acta 45, 1462 (1962b).Google Scholar
  98. —, St. Guttmann, and R.A. Boissonnas: Personal communication (1958).Google Scholar
  99. Jarvis, D., M. Bodanszky, and V. Du Vigneaud: The synthesis of l-(Hemi-homocystine)-oxytocin and a study of some of its pharmacological properties. J. Amer. chem. Soc. 83, 4780 (1961).Google Scholar
  100. —, B.M. Ferrier, and V. Du Vigneaud: The effect of increasing the size of the ring present in deamino-oxytocin by one méthylène group on its biological properties. J. biol. Chem. 240, 3553 (1965).PubMedGoogle Scholar
  101. —, and V. Du Vigneaud: Crystalline deamino-oxytocin. Science 143, 545 (1964).PubMedGoogle Scholar
  102. Jeffers, W. A., M.M. Livezey, and J. H. Austin: A method for demonstrating an antidiuretic action of minute amounts of pitressin: statistical analysis of results. Proc. Soc. exp. Biol. (N.Y.) 50, 184 (1942).Google Scholar
  103. Jošt, K., V.G. Debabov, H. Nesvadba, and J. Rudinger: Amino acids and peptides. XLII. A synthesis of dethiooxytocin and other acyclic peptides related to oxytocin. Collection Czech. Chem. Commun. 29, 419 (1964).Google Scholar
  104. —, J. Rudinger, and F. Sorm: Analogues of oxytocin modified in positions 1 and 2 of the peptide chain: protected intermediates. Collection Czech. Chem. Commun. 26, 2496 (1961).Google Scholar
  105. F. Sorm —: Structural analogues of oxytocin modified in position 2 of the peptide chain: preparation and some chemical and biological properties. Collection Czech. Chem. Commun. 28, 1706 (1963a).Google Scholar
  106. F. Sorm —: Analogues of oxytocin exerting protracted biological effects. Collection Czech. Chem. Commun. 28, 2021 (1963b).Google Scholar
  107. Katsoyannis, P.G.: Oxypressin, a synthetic octapeptide amide with hormonal properties. J. Amer. chem. Soc. 79, 109 (1957).Google Scholar
  108. —, and V. Du Vigneaud: The synthesis of the histidine analog of the vasopressins. Arch. Biochem. 78, 555 (1958).PubMedGoogle Scholar
  109. —: Arginine-vasotocin. Nature (Lond.) 184, 1465 (1959).Google Scholar
  110. Kimbrotjgh, R. D. Jr., W. D. Cash, L. A. Branda, W.Y. Chan, and V. Du Vigneaud: Synthesis and biological properties of l-desamino-8-lysine-vasopressin. J. biol. Chem. 238, 1411 (1963).Google Scholar
  111. —, and V. Du Vigneaud: Lysine-vasotocin, a synthetic analogue of the posterior pituitary hormones containing the ring of oxytocin and the side chain of lysine-vasopressin. J. biol. Chem. 236, 778 (1961).Google Scholar
  112. Klingenström, P., B. Nylén, and L. Westermark: A clinical comparison between adrenaline and Octapressin as vasoconstrictors in local anaesthesia. Acta anaesth. scand. 11, 35 (1967).Google Scholar
  113. — — —: Synthetic pituitary posterior-lobe hormones as vasoconstrictors in local anaesthesia. 2nd European Congress of Anaesthesiology, Copenhagen, 8-13 August, 1966.Google Scholar
  114. Konzett, H., and B. Berde: Personal communication (1958).Google Scholar
  115. B. Berde —: The biological activity of a new analogue of oxytocin in which the tyrosyl group is replaced by phenylalanyl. Brit. J. Pharmacol. 14, 133 (1959).PubMedGoogle Scholar
  116. Law, H.D., and V. Du Vigneaud: Synthesis of 2-p-methoxy-phenylalanine oxytocin (O-methyl-oxytocin) and some observations on its pharmacological behavior. J. Amer. chem. Soc. 82, 4579 (1960).Google Scholar
  117. Lutz, W.B., C. Kessler, D.E. Nettleton Jr., and V. Du Vigneaud: Isoasparagine-oxytocin: the isoasparagine isomer of oxytocin. J. Amer. chem. Soc. 81, 167 (1959).Google Scholar
  118. Manning, M., and V. Du Vigneaud: 4-ß-alanine-oxytocin: an oxytocin analog containing a twenty-one-membered disulfide ring. Biochemistry 4, 1884 (1965a).Google Scholar
  119. —: 6-hemi-D-cystine-oxytocin, a diastereoisomer of the posterior pituitary hormone oxytocin. J. Amer. chem. Soc. 87, 3978 (1965b).Google Scholar
  120. Massi, G.B., J.J. Poseiro, R. Caldeyro-Barcia, and V. Du Vigneaud: Effetti della desa-mino-ossitocina sulla contrattilità dell’utero umano a termine di gravidanza. Riv. Ostet. Ginec. 20, 77 (1965).PubMedGoogle Scholar
  121. Meienhofer, J., and V. Du Vigneaud: Synthesis of a biologically active analog of lysine-vasopressin, with phenylalanine replacing tyrosine: 2-phenylalanine lysine-vasopressin. J. Amer. chem. Soc. 82, 6336 (1960).Google Scholar
  122. —: Synthesis of a lysine-vasopressin derivative with a methyl substituent on the imino nitrogen of the peptide bond between lysine and glycinamide (9-sarcosine lysine-vasopressin). J. Amer. chem. Soc. 83, 142 (1961).Google Scholar
  123. Missura, T., u. A. Weder: Vergleichende Untersuchungen über das Verhalten des Kreislaufes bei der Tonsillektomie in LA mit vasokonstriktorischem Zusatz von Adrenalin bzw. PLV 2. Pract. oto-rhino-laryng. (Basel) 24, 249 (1962).Google Scholar
  124. Munsick, R. A.: Effect of magnesium ion on the response of the rat uterus to neurohypo-physial hormones and analogues. Endocrinology 66, 451 (1960).Google Scholar
  125. Nesvadba, H., J. Honzl, and J. Rudinger: Some structural analogues of oxytocin modified in position 3 of the peptide chain: synthesis and some chemical and biological properties. Collection Czech. Chem. Commun. 28, 1691 (1963).Google Scholar
  126. Photaki, I., and V. Du Vigneaud: 4-deamido-oxytocin, an analog of the hormone containing glutamic acid in place of glutamine. J. Amer. chem. Soc. 87, 908 (1965).Google Scholar
  127. Pickering, B.T., and H. Heller: Chromatographic and biological characteristics of fish and frog neurohypophysial extracts. Nature (Lond.) 184, 1463 (1959).Google Scholar
  128. Pliška, V., and I. Krejčí: The dose-response relation of the antidiuretic and vasopressor activities of 4-asparagine-8-lysine-vasopressin. Arch. int. Pharmacodyn. 161, 289 (1966).PubMedGoogle Scholar
  129. Rawstron, R. E.: A trial of phenyl-lysine-vasopressin (Octapressin) as a haemostatic agent. N. Z. med. J. 63, 297 (1964).PubMedGoogle Scholar
  130. Ressler, Ch.: The cyclic disulfide ring of oxytocin. Proc. Soc. exp. Biol. (N.Y.) 92, 725 (1956).Google Scholar
  131. —, and J. R. Rachele: Further properties of isoglutamine-oxytocin; inhibition of pressor activity of vasopressin. Proc. Soc. exper. Biol. (N.Y.) 98, 170 (1958).Google Scholar
  132. —, and V. Du Vigneaud: The isoglutamine isomer of oxytocin: its synthesis and comparison with oxytocin. J. Amer. chem. Soc. 79, 4511 (1957).Google Scholar
  133. Rudinger, J., J. Honzl and M. Zaoral: Syntheses in the oxytocin field. IV. Two analogues. Collection Czech. Chem. Commun. 21, 770 (1956).Google Scholar
  134. —, and K. Jost: A biologically active analogue of oxytocin not containing a disulfide group. Experientia (Basel) 20, 570 (1964).Google Scholar
  135. Saameli, K.: Quantitative comparison between oxytocin and four related neurohypophysial peptides on the human uterus in situ. Brit. J. Pharmacol. 23, 176 (1964).PubMedGoogle Scholar
  136. Sawyer, W. H.: Differences in the antidiuretic responses of rats to the intravenous administration of lysine and arginine vasopressins. Endocrinology 63, 694 (1958).PubMedGoogle Scholar
  137. —: Neurohypophysial hormones. Pharmacol. Rev. 13, 225 (1961).PubMedGoogle Scholar
  138. —: Vertebrate neurohypophysial principles. Endocrinology 73, 981 (1964).Google Scholar
  139. —: Active neurohypophysial principles from a cyclostome (Petromyzon marinus) and two cartilaginous fishes (Squalus acanthias and Hydrolagus collei). Gen. comp. Endocr. 5, 427 (1965).PubMedGoogle Scholar
  140. —, and H. B. Van Dyke: Isolation of the oxytocin-like pituitary principle of a teleost fish (Pollachius virens) and comparison of its properties with those of synthetic 4-serine, 8-isoleucine oxytocin. Endocrinology 73, 394 (1963a).PubMedGoogle Scholar
  141. —: Principles resembling oxytocin in neurohypophyses of fishes. Fed. Proc. 22, 386 (1963 b).Google Scholar
  142. —, R.A. Munsick, and H.B. Van Dyke: Pharmacological evidence for the presence of arginine vasotocin and oxytocin in neurohypophysial extracts from cold-blooded vertebrates. Nature (Lond.) 184, 1464 (1959).Google Scholar
  143. Schild, H.O.: A method of conducting a biological assay on a preparation giving repeated graded responses illustrated by the estimation of histamine. J. Physiol. (Lond.) 101, 115 (1942).Google Scholar
  144. Schneider, C.H., and V. Du Vigneaud: Synthesis of D-leucine-oxytocin, a biologically active diastereoisomer of oxytocin, and demonstration of its separability from oxytocin upon countercurrent distribution. J. Amer. chem. Soc. 84, 3005 (1962).Google Scholar
  145. Siedel, W., K. Sturm u. R. Geiger: Synthese eines vasopressorisch wirkenden Peptids: [O-Methyl-tyrosin]2-Lysin8-Vasopressin (Omtlv). Chem. Ber. 96, 1436 (1963).Google Scholar
  146. Sousa, R. C. De, J. Delaere, and B. Berde: Inappropriate secretion of vasopressin. Lancet 1965/1, 436.Google Scholar
  147. Sund, R. B.: A sensitive method for estimation of ergometrine, based upon serotonin antagonism on isolated rat uterus. Acta pharmacol. (Kbh). 20, 233 (1963).Google Scholar
  148. Studer, R.O., and W.D. Cash: Synthesis of l-acetyl-8-arginine-vasopressin and a study of its effects in the rat pressor assay. J. biol. Chem. 238, 657 (1963).PubMedGoogle Scholar
  149. Stürmer, E., R.L. Huguenin, R.A. Boissonnas, and B. Berde: Deamino1-phenylalanine2-arginine8-vasopressin: a peptide with highly selective antidiuretic activity. Experientia (Basel) 21, 583 (1965).Google Scholar
  150. Thompson, R.E.: Biological assay of posterior pituitary. J. Pharmacol, exp. Ther. 80, 373 (1944).Google Scholar
  151. Thorn, N.A.: A densimetric method for assay of small amounts of antidiuretic hormone. J. exp. Med. 105, 585 (1957).PubMedGoogle Scholar
  152. Tindal, J.S., and A. Yokoyama: Assay of oxytocin by the milk-ejection response in the anesthetized lactating guinea-pig. Endocrinology 71, 196 (1962).PubMedGoogle Scholar
  153. Tsaktris, A., u. P. Haemmeri, and A. Bühlmann: Reduction of portal venous pressure in cirrhotic patients with bleeding from oesophageal varices, by administration of a vasopressin derivative, phenylalanine2-lysine8-vasopressin. Amer. J. Med. 36, 825 (1964).Google Scholar
  154. Tyrode, M. V.: The mode of action of some purgative salts. Arch. int. Pharmacodyn. 20, 205 (1910).Google Scholar
  155. United States Pharmacopeia, 17th Rev. Easton, Pa: Mack Printing Co. 1965.Google Scholar
  156. Vigneaud, V. Du, G. S. Denning, S. Drabarek, and W.Y. Chan: The effect of replacement of the carboxamide group by hydrogen in the glutamine or asparagine residue of oxytocin on its biological activity. J. biol. Chem. 238, PC 1560 (1963).Google Scholar
  157. S. Drabarek, and W.Y. Chan —: The synthesis and pharmacological study of 4-decarboxamido-oxytocin (4-α-aminobutyric acid-oxytocin) and 5-decarboxamido-oxytocin (5-alanine-oxytocin). J. biol. Chem. 239, 472 (1964).Google Scholar
  158. —, P.S. Fitt, M. Bodanszky, and M. O’Connell: Synthesis and some pharmacological properties of a peptide derivative of oxytocin: glycyloxytocin. Proc. Soc. exp. Biol. (N.Y.) 104, 653 (1960a).Google Scholar
  159. —, G. Flouret, and R. Walter: Synthesis and some biological properties of 4-valine-oxytocin and l-deamino-4-valine-oxytocin. J. biol. Chem. 241, 2093 (1966).PubMedGoogle Scholar
  160. —, G. Winestock, V.V.S. Murti, D.B. Hope, and R.D. Kimbrough Jr.: Synthesis of l-ß-mercaptopropionic acid oxytocin (desamino-oxytocin), a highly potent analogue of oxytocin. J. biol. Chem. 235, PC 64 (1960b).Google Scholar
  161. Vogel, G., u. J. Hergott: Pharmakologische Untersuchungen über 0-Methyl-tyrosin2-lysin8-Vasopressin. Arzneimittel-Forsch. 13, 415 (1963).Google Scholar
  162. Walter, R., and V. Du Vigneaud: 6-hemi-L-selenocystine-oxytocin and l-deamino-6-hemi-L-selenocystine-oxytocin, highly potent isologs of oxytocin and l-deamino-oxytocin. J. Amer. chem. Soc. 87, 4192 (1965).Google Scholar
  163. —: l-deamino-l,6-L-selenocystine-oxytocin, a highly potent isolog of 1-deamino-oxytocin. J. Amer. chem. Soc. 88, 1331 (1966).Google Scholar
  164. Yamashiro, D., D. Gillessen, and V. Du Vigneaud: Simultaneous synthesis of 1-hemi-D-cystine-oxytocin and oxytocin and separation of the diastereoisomers by partition chroma-tography on Sephadex and by countercurrent distribution. J. Amer. chem. Soc. 88, 1310 (1966).Google Scholar
  165. Zaoral, M., E. Kasafírek, J. Rudinger, and F. Šorm: Amino acids and peptides. LI. Synthesis of 2-O-methyltyrosine-and 2-O-ethyltyrosine-lysine-vasopressin. Collection Czech. Chem. Commun. 30, 1869 (1965).Google Scholar
  166. —, J. Kolc, and F. Sorm: Synthesis of D-Arg8-and D-Lys8-vasopressin. Collection Czech. Chem. Commun. 31, 382 (1966).Google Scholar
  167. —, and F. Sorm: Amino acids and peptides. LV. Synthesis of Gly-CysMysine-vasopressin and Gly-Cys1-Tyr(Me)2-lysine-vasopressin. Collection Czech. Chem. Commun. 30, 2812 (1965).Google Scholar
  168. —: Amino acids and peptides. LIX. Synthesis and some biological properties of L-Dab8-vasopressin. Collection Czech. Chem. Commun. 31, 90 (1966a).Google Scholar
  169. —: Amino acids and peptides. LX. Synthesis of D-Dab8-vasopressin. Collection Czech. Chem. Commun. 31, 310 (1966b).Google Scholar
  170. Zhuze, A.L., K. Jost, E. Kasafíree:, and J. Rudinger: Amino acids and peptides. XLV. Analogues of oxytocin with O-ethyltyrosine, p-methylphenylalanine and p-ethylphenyl-alanine replacing tyrosine. Collection Czech. Chem. Commun. 29, 2648 (1964).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1968

Authors and Affiliations

  • B. Berde
  • R. A. Boissonnas

There are no affiliations available

Personalised recommendations